0001851933-21-000001.txt : 20210318
0001851933-21-000001.hdr.sgml : 20210318
20210318105742
ACCESSION NUMBER: 0001851933-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210318
DATE AS OF CHANGE: 20210318
EFFECTIVENESS DATE: 20210318
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: VIN-24 Neurexis Therapeutics, LLC
CENTRAL INDEX KEY: 0001851933
IRS NUMBER: 862041070
STATE OF INCORPORATION: AR
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-392691
FILM NUMBER: 21753494
BUSINESS ADDRESS:
STREET 1: 535 W. RESEARCH CENTER BLVD.
STREET 2: SUITE 135
CITY: FAYETTEVILLE
STATE: AR
ZIP: 72701
BUSINESS PHONE: 4795212592
MAIL ADDRESS:
STREET 1: 535 W. RESEARCH CENTER BLVD.
STREET 2: SUITE 135
CITY: FAYETTEVILLE
STATE: AR
ZIP: 72701
D
1
primary_doc.xml
X0708
D
LIVE
0001851933
VIN-24 Neurexis Therapeutics, LLC
535 W. RESEARCH CENTER BLVD.
SUITE 135
FAYETTEVILLE
AR
ARKANSAS
72701
4795212592
ARKANSAS
None
None
Limited Liability Company
true
2021
Robert
Calvin
Goforth
535 W. Research Center Blvd.
Suite 135
Fayetteville
AR
ARKANSAS
72701
Executive Officer
Director
CEO of Manager.
Other
Decline to Disclose
- 06b
false
2021-03-09
false
true
false
5000
None
None
None
None
N/A
N/A
Fayetteville
AR
ARKANSAS
72701
AR
ARKANSAS
TX
TEXAS
false
500000
50000
450000
false
7
0
0
0
false
VIN-24 Neurexis Therapeutics, LLC
Robert Calvin Goforth
Robert Calvin Goforth
CEO of Manager
2021-03-18